Dacotin RTU 50 Injection
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Oxaliplatin (50mg)
Overview Dacotin RTU 50 Injection
Colorectal cancer is treated with Dacotin RTU 50 Injection, a medication that inhibits or reduces cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician and may vary. Adhere strictly to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. While therapeutic effects may not be immediately apparent (taking several weeks or months), discontinue use only as directed. Common side effects include nausea, fatigue, vomiting, and diarrhea. This medication can lower blood cell counts (red and white), increasing infection risk. Severe allergic reactions (e.g., mouth sores, rash, itching, breathing difficulties) necessitate immediate medical attention. Regular blood tests monitor blood cell levels, along with heart, liver, and uric acid levels. Prior to treatment, disclose any existing heart, liver, or kidney conditions, or concurrent medications (especially anti-infectives), to your physician. Interactions with other drugs are possible; inform your healthcare provider of all medications. Use is contraindicated during pregnancy and breastfeeding. Due to potential infertility in men, sperm preservation should be discussed with a doctor before treatment commences. Driving is discouraged due to potential dizziness.
Uses of Dacotin RTU 50 Injection
Colorectal cancer
Major Benefits of Dacotin RTU 50 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Dacotin RTU 50 Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Dacotin RTU 50 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Dacotin RTU 50 Injection works:
Dacotin RTU 50 Injection is a cancer treatment that functions by disrupting the genetic structure (DNA and RNA) within cancerous cells, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Dacotin RTU 50 Injection lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Dacotin RTU 50 Injection during pregnancy is contraindicated due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Dacotin RTU 50 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Dacotin RTU 50 Injection or undergoing Oxaliplatin treatment might induce adverse reactions, including dizziness, nausea, vomiting, and other neurological symptoms impacting ambulation. These effects could impair driving ability.
KidneyCAUTION
Exercise caution when administering Dacotin RTU 50 Injection to individuals with advanced renal impairment; dosage modification may be necessary. Consult a physician for guidance. Data regarding Dacotin RTU 50 Injection use in such patients is limited. Dosage alteration isn't advised for those with less severe kidney dysfunction.
LiverCAUTION
For individuals with hepatic impairment, administering Dacotin RTU 50 Injection requires careful consideration. Dosage modification of Dacotin RTU 50 Injection might be necessary. Physician consultation is advised.
What if you forget to take Dacotin RTU 50 Injection :
Omit a Dacotin RTU 50 Injection dose? Seek medical advice immediately.
Facts to Know About Dacotin RTU 50 Injection
| Label | Value |
|---|---|
| Chemical Type | Platinum Equivalents |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Category | Platinum-based Anticancer Agents |
3,018 People bought this recently